Drug Treatments for Alzheimer's Disease: Shifting the Burden of Care

Author： Max W.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.11, Iss.5, 1999-05, pp. : 363-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatments in Development for Alzheimer's Disease

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 1, 2012-03 ,pp. : 58-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 149-162

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Alzheimer’s Disease - Mechanisms, Drug Targets and Alternative Treatments)

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 470-471

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Rivastigmine on Caregiver Burden Associated with Alzheimer's Disease in Both Informal Care and Nursing Home Settings

By Grossberg George T.  

Drugs & Aging, Vol. 25, Iss. 7, 2008-01 ,pp. : 573-584

Adis International

Access to resources Recommend Favorite

New and emerging treatments for Alzheimer's disease

By Corbett Anne   Ballard Clive  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 147-156

Informa Healthcare

Access to resources Recommend Favorite